Loading clinical trials...
Loading clinical trials...
Despite continuous technical improvements in urologic surgery, up to 40% of prostate cancer patients will develop biochemical recurrence after radical prostatectomy (RP), potentially because of micro ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT07004582 · Prostate Cancer, Prostate Cancer Metastatic Disease, and more
NCT07131956 · Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant, and more
NCT05036226 · Prostate Cancer Recurrent, Solid Tumor, Adult
NCT06508567 · Prostate Cancer Recurrent, Prostate Cancer
NCT05022914 · Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, and more
Medical University of Vienna
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions